ArticleClinical and experimental gastroenterology2014

Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis.

Ram Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.